Litcius/Paper detail

Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry

Zilun Li, Meixiu Peng, Pin Chen, Chenshu Liu, Ao Hu, Yixin Zhang, Jiangyun Peng, Jiang Liu, Yihui Li, Wenxue Li, Wei Zhu, Dongxian Guan, Yang Zhang, Hongyin Chen, Jiuzhou Li, Dongxiao Fan, Kan Huang, Fen Lin, Zefeng Zhang, Zeling Guo, Hengli Luo, Xi He, Yuan‐Yuan Zhu, Linghua Li, Bingding Huang, Weikang Cai, Lei Gu, Yutong Lu, Kai Deng, Li Yan, Sifan Chen

2022Cell Metabolism59 citationsDOIOpen Access PDF

Topics & Concepts

ImatinibVirtual screeningEnzymePharmacologyAllosteric regulationIn vivoMedicineBiologyChemistryCancer researchDrug discoveryBioinformaticsBiochemistryGeneticsMyeloid leukemiaPhagocytosis and Immune RegulationCOVID-19 Clinical Research StudiesPancreatic function and diabetes
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry | Litcius